News for Healthier Living

FDA Approval Opens New Chapter in Pancreatic Cancer Treatment

FDA Approval of Rasonque (daraxonrasib), represents a monumental shift in the treatment of pancreas cancer and demonstrates that RAS, one of the most important drivers of pancreatic cancer, can be successfully targeted.

August 27, 2026


September 8 2026

September 7 2026

September 5 2026

September 4 2026

September 3 2026

September 2 2026

September 1 2026

August 31 2026

August 30 2026

August 29 2026

August 28 2026

August 27 2026

August 26 2026

August 25 2026